ZA942140B - Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy - Google Patents
Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapyInfo
- Publication number
- ZA942140B ZA942140B ZA942140A ZA942140A ZA942140B ZA 942140 B ZA942140 B ZA 942140B ZA 942140 A ZA942140 A ZA 942140A ZA 942140 A ZA942140 A ZA 942140A ZA 942140 B ZA942140 B ZA 942140B
- Authority
- ZA
- South Africa
- Prior art keywords
- alpha
- phenyl
- useful
- pyridineethanamine
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GB1993/000689 WO1993020052A1 (en) | 1992-04-03 | 1993-04-01 | Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA942140B true ZA942140B (en) | 1994-10-03 |
Family
ID=10728731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA942140A ZA942140B (en) | 1993-04-01 | 1994-03-25 | Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0691958B1 (xx) |
JP (1) | JP3023988B2 (xx) |
AT (1) | ATE156814T1 (xx) |
AU (1) | AU682350B2 (xx) |
CA (1) | CA2159480C (xx) |
DE (1) | DE69404975T2 (xx) |
DK (1) | DK0691958T3 (xx) |
ES (1) | ES2105679T3 (xx) |
FI (1) | FI109019B (xx) |
GR (1) | GR3025082T3 (xx) |
NO (1) | NO304648B1 (xx) |
WO (1) | WO1994022832A1 (xx) |
ZA (1) | ZA942140B (xx) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3422191A (en) * | 1965-01-21 | 1969-01-14 | Synergistics Inc | Compositions and methods for tranquilization employing salts of n-morpholine ethanol |
GB9320273D0 (en) * | 1993-04-01 | 1993-11-17 | Fisons Corp | Compound useful in therapy |
EP0648489A1 (en) * | 1988-08-12 | 1995-04-19 | Fisons Corporation | Arylalkylamides having neuroprotective properties |
JP2514855B2 (ja) * | 1990-08-08 | 1996-07-10 | キッセイ薬品工業株式会社 | 光学活性なアラニンアニリド誘導体の酸付加塩 |
PL180014B1 (pl) * | 1992-04-03 | 2000-11-30 | Astra Ab | (S)- a-fenylo-2-pirydoetanoamina i kompozycja farmaceutyczna zawierajaca (S)- a-fenylo-2-pirydoetanoamine PL PL PL PL PL PL |
-
1994
- 1994-03-25 ZA ZA942140A patent/ZA942140B/xx unknown
- 1994-04-05 AU AU64337/94A patent/AU682350B2/en not_active Expired
- 1994-04-05 DK DK94912016.6T patent/DK0691958T3/da active
- 1994-04-05 CA CA002159480A patent/CA2159480C/en not_active Expired - Lifetime
- 1994-04-05 JP JP6521865A patent/JP3023988B2/ja not_active Expired - Lifetime
- 1994-04-05 ES ES94912016T patent/ES2105679T3/es not_active Expired - Lifetime
- 1994-04-05 DE DE69404975T patent/DE69404975T2/de not_active Expired - Lifetime
- 1994-04-05 EP EP94912016A patent/EP0691958B1/en not_active Expired - Lifetime
- 1994-04-05 WO PCT/GB1994/000716 patent/WO1994022832A1/en active IP Right Grant
- 1994-04-05 AT AT94912016T patent/ATE156814T1/de active
-
1995
- 1995-09-28 NO NO953846A patent/NO304648B1/no not_active IP Right Cessation
- 1995-09-29 FI FI954646A patent/FI109019B/fi not_active IP Right Cessation
-
1997
- 1997-10-17 GR GR970402723T patent/GR3025082T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0691958T3 (da) | 1997-12-08 |
WO1994022832A1 (en) | 1994-10-13 |
DE69404975D1 (de) | 1997-09-18 |
CA2159480A1 (en) | 1994-10-13 |
DE69404975T2 (de) | 1997-12-18 |
FI954646A0 (fi) | 1995-09-29 |
NO953847L (no) | 1995-11-22 |
EP0691958A1 (en) | 1996-01-17 |
AU682350B2 (en) | 1997-10-02 |
JP3023988B2 (ja) | 2000-03-21 |
JPH08508475A (ja) | 1996-09-10 |
GR3025082T3 (en) | 1998-01-30 |
FI954646A (fi) | 1995-11-29 |
EP0691958B1 (en) | 1997-08-13 |
NO953847D0 (no) | 1995-09-28 |
NO304648B1 (no) | 1999-01-25 |
FI109019B (fi) | 2002-05-15 |
CA2159480C (en) | 2005-01-25 |
AU6433794A (en) | 1994-10-24 |
ATE156814T1 (de) | 1997-08-15 |
ES2105679T3 (es) | 1997-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1438295A (en) | Method for treatment of papulo-pustules and comedones of the skin | |
AP9300555A0 (en) | Therapeutic agent and its use | |
SG48204A1 (en) | Salt of (s)-alpha-phenyl-2-pyridineethanamine useful in therapy | |
EP0858340A4 (en) | COMBINATION THERAPY FOR TREATING DIABETES AND OBESITY | |
IL107768A0 (en) | Treatment of agricultural produce | |
ZA942140B (en) | Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy | |
EP0733365A3 (en) | Use of benzoquinolin-3-one for the treatment and prevention of prostate cancer | |
GB2280848B (en) | Skin treatment apparatus | |
AU1192495A (en) | Use of selegiline and its derivatives for the treatment of psoriasis | |
GB9312780D0 (en) | Therapeutic and cosmetic treatment | |
LV10385B (en) | Use of quinons in the treatment of cancer or aids | |
ZA964382B (en) | Lymphotoxin and thrombopoietin for use in the treatment of cancer. | |
GB9303688D0 (en) | Therapeutic treatment | |
ZA937015B (en) | Treatment and diagnosis of cancer | |
IL106658A0 (en) | Cancer diagnosis and treatment | |
EG19885A (en) | Medicament for the treatment of hyperlipidaemia and/or atherosolerosis | |
LTIP581A (en) | Pharmaceutical and its use for the treatment of states of agitation and nerve dysfunctions | |
GB9310611D0 (en) | Skin treatment | |
GB9213592D0 (en) | Cancer prevention and therapy | |
BG98001U (en) | Medicament for the treatment of hyperkeratotic conditions of the skin | |
GB9226313D0 (en) | Therapeutic treatment | |
GEP19971009B (en) | Flupirtine in combination with antiparkinsonica against muscle bracing | |
AU5381794A (en) | Treatment and diagnosis of cancer |